Centessa Pharmaceuticals plc. (CNTA) NASDAQ

$4.52 -0.08 (-1.74%)

Market Cap: $425.07M

As of 06/27/22 04:00 PM EDT. Market closed.

(CNTA)

Centessa Pharmaceuticals plc. (CNTA) NASDAQ

$4.52 -0.08 (-1.74%)

Market Cap: $425.07M

As of 06/27/22 04:00 PM EDT. Market closed.

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
2,021
URL
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$0
Previous Close
$4.60
Days Range
$4.37 - $4.59
52 week range
$2.89 - $25.98
Volume
81,011
Avg. Volume (30 days)
590,759
Market Cap
$425.07M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
94,041,029
Open
$0
Previous Close
$4.60
Days Range
$4.37 - $4.59
52 week range
$2.89 - $25.98
Volume
81,011
Avg. Volume (30 days)
590,759
Market Cap
$425.07M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
94,041,029

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CENTESSA PHARMACEUTICALS PLC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
SAHA SAURABH Chief Executive Officer Jun 24, 2022 Buy $4.63 10,000 46,284 38,000 Jun 27, 2022, 09:28 PM
YVER ANTOINE EVP & Chairman of Development Jun 17, 2022 Sale $4.68 9,200 43,036 739,697 Jun 21, 2022, 07:23 PM
YVER ANTOINE EVP & Chairman of Development May 17, 2022 Sale $5.42 20,222 109,632 813,675 May 19, 2022, 06:01 PM
YVER ANTOINE EVP & Chairman of Development May 18, 2022 Sale $5.10 64,778 330,102 748,897 May 19, 2022, 06:01 PM
SAHA SAURABH Chief Executive Officer Feb 02, 2022 Buy $9.74 5,000 48,700 28,000 Feb 04, 2022, 08:30 AM
GRAINGER DAVID J Chief Innovation Officer Jan 28, 2022 Buy $9.05 27,500 248,754 27,500 Feb 01, 2022, 08:15 PM
De Rubertis Francesco Director Dec 02, 2021 Buy $12.82 34,326 440,059 3,936,970 Dec 06, 2021, 05:31 PM
Medicxi Ventures Management (Jersey) Ltd 10% Owner Dec 02, 2021 Buy $12.82 34,326 440,059 3,936,970 Dec 06, 2021, 05:11 PM
De Rubertis Francesco Director Nov 30, 2021 Buy $11.62 36,847 428,162 3,844,535 Dec 02, 2021, 05:24 PM
De Rubertis Francesco Director Dec 01, 2021 Buy $12.62 60,304 761,036 3,903,440 Dec 02, 2021, 05:24 PM
Medicxi Ventures Management (Jersey) Ltd 10% Owner Dec 01, 2021 Buy $12.62 60,304 761,036 3,903,440 Dec 02, 2021, 05:10 PM
Medicxi Ventures Management (Jersey) Ltd 10% Owner Nov 30, 2021 Buy $11.62 36,847 428,162 3,844,535 Dec 02, 2021, 05:10 PM
De Rubertis Francesco Director Nov 29, 2021 Buy $11.70 56,706 663,477 3,808,543 Nov 30, 2021, 05:26 PM
De Rubertis Francesco Director Nov 26, 2021 Buy $11.34 11,817 133,949 3,753,152 Nov 30, 2021, 05:26 PM
Medicxi Ventures Management (Jersey) Ltd 10% Owner Nov 29, 2021 Buy $11.70 56,706 663,477 3,808,543 Nov 30, 2021, 05:11 PM
Medicxi Ventures Management (Jersey) Ltd 10% Owner Nov 26, 2021 Buy $11.34 11,817 133,949 3,753,152 Nov 30, 2021, 05:11 PM
KANTOFF AARON Director Nov 18, 2021 Buy $11.98 10,000 119,850 60,000 Nov 18, 2021, 08:30 PM
SAHA SAURABH Chief Executive Officer Nov 16, 2021 Buy $12.28 23,000 282,472 23,000 Nov 18, 2021, 07:00 PM
Bush Tia L Chief Quality Officer Nov 16, 2021 Buy $12.46 5,000 62,302 8,000 Nov 18, 2021, 07:00 PM
De Rubertis Francesco Director Jun 02, 2021 Buy $20.00 600,000 12,000,000 3,741,609 Jun 04, 2021, 05:01 PM
CHAO DAVID M Chief Administrative Officer Jun 02, 2021 Buy $20.00 500 10,000 500 Jun 04, 2021, 05:00 PM
HUSSAIN IQBAL J General Counsel Jun 02, 2021 Buy $20.00 5,500 110,000 5,500 Jun 04, 2021, 05:00 PM
HUSSAIN IQBAL J General Counsel Jun 02, 2021 Buy $20.00 3,000 60,000 3,000 Jun 04, 2021, 05:00 PM
GOYAL ARJUN Director Jun 02, 2021 Buy $20.00 750,000 15,000,000 3,825,659 Jun 04, 2021, 05:00 PM
Thorell Marella Chief Accounting Officer Jun 02, 2021 Buy $20.00 1,000 20,000 1,000 Jun 04, 2021, 05:00 PM
Weinhoff Gregory M Chief Financial Officer Jun 02, 2021 Buy $20.00 10,000 200,000 10,000 Jun 04, 2021, 05:00 PM
Medicxi Ventures Management (Jersey) Ltd 10% Owner Jun 02, 2021 Buy $20.00 600,000 12,000,000 3,741,609 Jun 04, 2021, 04:30 PM
GAP (Bermuda) LTD 10% Owner Jun 02, 2021 Buy $20.00 1,500,000 30,000,000 9,681,818 Jun 03, 2021, 12:24 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
SAHA SAURABH Chief Executive Officer 06/24/2022 46,284
YVER ANTOINE EVP & Chairman of Development 06/17/2022 43,036
YVER ANTOINE EVP & Chairman of Development 05/17/2022 109,632
YVER ANTOINE EVP & Chairman of Development 05/18/2022 330,102
SAHA SAURABH Chief Executive Officer 02/02/2022 48,700
GRAINGER DAVID J Chief Innovation Officer 01/28/2022 248,754
De Rubertis Francesco Director 12/02/2021 440,059
Medicxi Ventures Management (Jersey) Ltd 10% Owner 12/02/2021 440,059
De Rubertis Francesco Director 11/30/2021 428,162
De Rubertis Francesco Director 12/01/2021 761,036
Medicxi Ventures Management (Jersey) Ltd 10% Owner 12/01/2021 761,036
Medicxi Ventures Management (Jersey) Ltd 10% Owner 11/30/2021 428,162
De Rubertis Francesco Director 11/29/2021 663,477
De Rubertis Francesco Director 11/26/2021 133,949
Medicxi Ventures Management (Jersey) Ltd 10% Owner 11/29/2021 663,477
Medicxi Ventures Management (Jersey) Ltd 10% Owner 11/26/2021 133,949
KANTOFF AARON Director 11/18/2021 119,850
SAHA SAURABH Chief Executive Officer 11/16/2021 282,472
Bush Tia L Chief Quality Officer 11/16/2021 62,302
De Rubertis Francesco Director 06/02/2021 12,000,000
CHAO DAVID M Chief Administrative Officer 06/02/2021 10,000
HUSSAIN IQBAL J General Counsel 06/02/2021 110,000
HUSSAIN IQBAL J General Counsel 06/02/2021 60,000
GOYAL ARJUN Director 06/02/2021 15,000,000
Thorell Marella Chief Accounting Officer 06/02/2021 20,000
Weinhoff Gregory M Chief Financial Officer 06/02/2021 200,000
Medicxi Ventures Management (Jersey) Ltd 10% Owner 06/02/2021 12,000,000
GAP (Bermuda) LTD 10% Owner 06/02/2021 30,000,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2021
06/30/2021
4.58%
2Q

Period of Report: 12/31/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2021
4.58%
2Q